Safe transfusion in Asian-type DEL.

In this issue of Blood, Ji and colleagues assemble evidence to justify trans-fusion of RhD+ red cells to individuals with RhD- cells in conventional typing but have the common Asian-type DEL mutant.1 Their evidence comes from many sources including direct clinical challenge, epidemiologic studies, and genomic and transcriptomic analysis and has potential implications for mil-lions of people.